Zinapar (darinaparsin) - Solasia, Meiji Seika, Nippon Kayaku
Disulfidptosis in pediatric AML: a multi-omics approach to risk stratification and potential therapeutic strategy. (PubMed, Cancer Cell Int) - Jun 3, 2025 - "In summary, this study employed multi-omics analysis to examine the characteristics of pAML in the context of disulfidptosis, identifying a novel disulfidptosis-related subtype, aiming to provide new insights for future studies on optimizing traditional regimen based on pAML pathogenesis." 
Journal • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Oncology • Pediatrics • SLC2A1 • SLC7A11
http://www.ncbi.nlm.nih.gov/pubmed/40457386
 
Aiguo Liu; Jiasi Zhang; Yaqin Wang; Yichen Lei
 
Jun 3, 2025
 
Prev Next